What is Asolva?
Asolva operates at the intersection of clinical necessity and software agility, championing a philosophy that rejects the one-size-fits-all approach to hospital management. Since its inception in 2000, the company has developed the Medici platform, a suite designed to bring consumer-grade usability to the often-cluttered healthcare IT space. By prioritizing extreme flexibility, Asolva enables institutions to tailor digital workflows to their specific operational requirements rather than forcing clinical staff to adapt to rigid, legacy systems. The company's track record includes high-profile partnerships with entities such as Microsoft, the Center for Disease Control and Prevention, and Kaiser Permanente, validating its role as a critical infrastructure provider in modern medical informatics.
How much funding has Asolva raised?
Asolva has raised a total of $337K across 2 funding rounds:
Debt
$150K
Debt
$187K
Debt (2020): $150K with participation from PPP
Debt (2021): $187K led by PPP
Key Investors in Asolva
PPP
Public-Private Partnership
What's next for Asolva?
With the successful closure of this late-stage debt financing, Asolva is well-positioned to accelerate its product roadmap and expand its footprint within the global healthcare market. The strategic allocation of this capital will likely focus on enhancing the Medici platform's interoperability and deepening its integration capabilities with existing electronic health record systems. As the industry shifts toward more personalized and data-driven patient care, Asolva's emphasis on adaptable software architecture provides a distinct competitive advantage. Moving forward, the company is expected to leverage its established reputation to capture additional market share among large-scale health systems seeking to modernize their digital infrastructure without sacrificing operational continuity.
See full Asolva company page
